SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:liu-156913"
 

Search: onr:"swepub:oai:DiVA.org:liu-156913" > Collagen proportion...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Collagen proportionate area is an independent predictor of long-term outcome in patients with non-alcoholic fatty liver disease

Buzzetti, Elena (author)
Royal Free Hosp, England; UCL, England
Hall, Andrew (author)
Royal Free Hosp, England; Royal Free Hosp, England
Ekstedt, Mattias (author)
Linköpings universitet,Avdelningen för kardiovaskulär medicin,Medicinska fakulteten,Region Östergötland, Magtarmmedicinska kliniken
show more...
Manuguerra, Roberta (author)
Royal Free Hosp, England
Misas, Marta Guerrero (author)
Royal Free Hosp, England; UCL, England
Covelli, Claudia (author)
Royal Free Hosp, England
Leandro, Gioacchino (author)
S de Bellis Res Hosp, Italy
Luong, TuVinh (author)
Royal Free Hosp, England
Kechagias, Stergios (author)
Linköpings universitet,Avdelningen för kardiovaskulär medicin,Medicinska fakulteten,Region Östergötland, Magtarmmedicinska kliniken
Manesis, Emanuel K. (author)
Hippokrateion Hosp, Greece
Pinzani, Massimo (author)
Royal Free Hosp, England; UCL, England
Dhillon, Amar P. (author)
Royal Free Hosp, England
Tsochatzis, Emmanuel A. (author)
Royal Free Hosp, England; UCL, England
show less...
 (creator_code:org_t)
2019-03-18
2019
English.
In: Alimentary Pharmacology and Therapeutics. - : WILEY. - 0269-2813 .- 1365-2036. ; 49:9, s. 1214-1222
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Background Collagen proportionate area (CPA) measurement is a technique that quantifies fibrous tissue in liver biopsies by measuring the amount of collagen deposition as a proportion of the total biopsy area. CPA predicts clinical outcomes in patients with HCV and can sub-classify cirrhosis. Aim To test the ability of CPA to quantify fibrosis and predict clinical outcomes in patients with NAFLD. Methods We assessed consecutive patients with biopsy-proven NAFLD from three European centres. Clinical and laboratory data were collected at baseline and at the time of the last clinical follow-up or death. CPA was performed at two different objective magnifications, whole biopsy macro and x4 objective magnification, named standard (SM) and high (HM) magnification respectively. The correlation between CPA and liver stiffness was assessed in a sub-group of patients. Results Of 437 patients, 32 (7.3%) decompensated and/or died from liver-related causes during a median follow-up of 103 months. CPA correlated with liver stiffness and liver fibrosis stage across the whole spectrum of fibrosis. HM CPA was significantly higher than SM CPA in stages F0-F3 but similar in cirrhosis, reflecting a higher ability to capture pericellular/perisinusoidal fibrosis at early stages. Age at baseline (HR: 1.04, 95% CI: 1.01-1.08), HM CPA (HR: 1.04 per 1% increase, 95% CI: 1.01-1.08) and presence of advanced fibrosis (HR: 15.4, 95% CI: 5.02-47.84) were independent predictors of liver-related clinical outcomes at standard and competing risk multivariate Cox-regression analysis. Conclusions CPA accurately measures fibrosis and is an independent predictor of clinical outcomes in NAFLD; hence it merits further evaluation as a surrogate endpoint in clinical trials.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Gastroenterologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Gastroenterology and Hepatology (hsv//eng)

Keyword

decompensation; fibroscan; fibrosis; prognosis; steatohepatitis

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view